Eagle Pharmaceuticals
EGRX
#9801
Rank
โ‚ฌ9.21 M
Marketcap
0,71ย โ‚ฌ
Share price
-11.76%
Change (1 day)
-91.99%
Change (1 year)

EPS for Eagle Pharmaceuticals (EGRX)

EPS in 2023 (TTM): 0,80ย โ‚ฌ

According to Eagle Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is 0,87ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of 2,67ย โ‚ฌ an increase over its 2021 EPS that were of -0,63ย โ‚ฌ.

EPS history for Eagle Pharmaceuticals from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)0,80ย โ‚ฌ-70.06%
20222,67ย โ‚ฌ-527.27%
2021-0,63ย โ‚ฌ-174.16%
20200,84ย โ‚ฌ-13.59%
20190,98ย โ‚ฌ-52.75%
20182,07ย โ‚ฌ-36.63%
20173,26ย โ‚ฌ-35.09%
20165,02ย โ‚ฌ1792.86%
20150,27ย โ‚ฌ-117.39%
2014-1,53ย โ‚ฌ71.62%
2013-0,89ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
13,35ย โ‚ฌ 1,431.01%๐Ÿ‡บ๐Ÿ‡ธ USA
3,32ย โ‚ฌ 280.51%๐Ÿ‡ฌ๐Ÿ‡ง UK
3,55ย โ‚ฌ 306.52%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-1,90ย โ‚ฌ-317.39%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
13,41ย โ‚ฌ 1,438.04%๐Ÿ‡บ๐Ÿ‡ธ USA
5,15ย โ‚ฌ 490.14%๐Ÿ‡บ๐Ÿ‡ธ USA
3,76ย โ‚ฌ 331.52%๐Ÿ‡บ๐Ÿ‡ธ USA